Earnings Preview — 5191 total
Mayville Engineering Company heads into its Q1 2026 earnings report with one of the clearest options sentiment reversals in its peer group. The shift is striking. The put/call ratio has collapsed to 0.19 — near its…
Trevi Therapeutics enters its May 7 earnings release with a meaningful short base still in place, even as the stock has rebounded sharply and the lending market suggests bears are not pressing harder. Short sellers…
Alcon heads into today's earnings call having delivered a Q1 beat on the bottom line — and a modest guidance raise — while the stock's recent slide had signalled growing caution in the weeks beforehand. The pre-print…
Ellington Financial Inc. heads into its Q1 2026 earnings today with the borrow market unusually relaxed — and short sellers who were pressing the stock hard last month now in retreat. Short interest has fallen sharply…
Ardent Health heads into its May 6 earnings call with the headline numbers already on the table — a Q1 beat that punched through modest expectations. The company posted Q1 EPS of $0.28, well clear of the $0.20…
Marqeta, Inc. reports Q1 2026 results on May 7 carrying a contradictory setup: the stock has quietly rallied 13% in a month, yet the analyst community has spent the past six months trimming targets and downgrading…
CURA headed into its Q1 2026 earnings with short sellers already retreating — and the results gave them little reason to return. The company posted Q1 EPS of $0.09, against a consensus estimate of $(0.06) — a $0.15…
Comstock Resources enters its Q1 2026 earnings call today with a short-seller presence that ranks in the top percentile of the market — and a price chart that validates their conviction. The short interest story is the…
BV heads into its fiscal Q2 2026 earnings call today with a mixed print already on the tape: revenue blew past estimates, but the bottom line fell short. The headline numbers split neatly between top and bottom.…
TALO enters its Q1 2026 earnings call today against a sharply divided backdrop — insider selling from its largest shareholder collides with an analyst community that has been steadily lifting price targets. The most…
VMD Misses on EPS but Lifts Guidance Viemed Healthcare walked into its Q1 2026 print with a clean lending market but a narrative already complicated by insider selling — and the numbers delivered a familiar split…
INMB heads into its May 7 earnings with one of the most aggressive short positions in the biotech universe — and a stock price that has quietly been rallying against it. Short sellers have dug in with real conviction.…
ANGI walks into its May 6 earnings report carrying one of the heavier short burdens in its peer group — yet the bears have been quietly retreating over the past month. Short interest now covers roughly 20.7% of the…
Granite Point Mortgage Trust heads into its Q1 2026 earnings today carrying a pattern of severe post-earnings selloffs that sets the bar for what the market will accept. The historical record is stark. Across the three…
Select Water Solutions heads into its Q1 2026 earnings today with options positioning markedly more defensive than usual, even as short sellers quietly retreat. The clearest signal is in the options market. The…
TRVG heads into its Q1 2026 earnings call — scheduled for today — with one signal dominating all others: an EPS momentum profile that ranks in the top 3% of the market. That is the genuine standout. On both the 30-day…
BlackLine heads into its May 7 Q1 2026 earnings report with short sellers firmly in place and options markets leaning defensively — a combination that frames the print as a test of the company's growth narrative at a…
Global Indemnity Group heads into its May 8 earnings release with a clear insider-buying signal that has persisted through the stock's recent pullback. The insider story is the standout here. CEO Joseph Brown has been…
Protagonist Therapeutics heads into its May 7 Q1 earnings with options markets flashing the most defensive signal of the past year. The put/call ratio has surged to 1.48 — nearly at its 52-week high and almost two…
Avalo Therapeutics reports on May 8 carrying one of the most contested short-interest profiles in small-cap biotech. The bear trade is substantial. Short interest has climbed to 30.7% of the free float — up 29% over…
